Juan José José Galano Frutos

Dr. Juan José José Galano Frutos

Universidad de Zaragoza, Zaragoza, Aragon, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
OSOusman Secka
Ousman Secka
DBDouglas E. Berg
Douglas E. Berg
MAMartin Antonio
Martin Antonio
TCTumani Corrah
Tumani Corrah
MTMary Tapgun
Mary Tapgun
JTJulian E. Thomas
Julian E. Thomas
Helicobacter pylori is a globally important and genetically diverse gastric pathogen that infects most people in developing countries. Eradication efforts are complicated by antibiotic resistance, which varies in frequency geographically. There are very few data on resistance in African strains. Sixty-four Gambian H. pylori strains were tested for antibiotic susceptibility. The role of rdxA in metronidazole (Mtz) susceptibility was tested by DNA transformation and sequencing; RdxA protein variants were interpreted in terms of RdxA structure. Forty-four strains (69%) were resistant to at least 8 μg of Mtz/ml. All six strains from infants, but only 24% of strains from adults, were sensitive ( P = 0.0031). Representative Mtz-resistant (Mtz r ) strains were rendered Mtz susceptible (Mtz s ) by transformation with a functional rdxA gene; conversely, Mtz s strains were rendered Mtz r by rdxA inactivation. Many mutations were found by Gambian H. pylori rdxA sequencing; mutations that probably inactivated rdxA in Mtz r strains were identified and explained using RdxA protein's structure. All of the strains were sensitive to clarithromycin and erythromycin. Amoxicillin and tetracycline resistance was rare. Sequence analysis indicated that most tetracycline resistance, when found, was not due to 16S rRNA gene mutations. These data suggest caution in the use of Mtz-based therapies in The Gambia. The increasing use of macrolides against respiratory infections in The Gambia calls for continued antibiotic susceptibility monitoring. The rich variety of rdxA mutations that we found will be useful in further structure-function studies of RdxA, the enzyme responsible for Mtz susceptibility in this important pathogen.

1 November 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
MPMaria Piñana
Maria Piñana
JVJorgina Vila
Jorgina Vila
CMCarolina Maldonado
Carolina Maldonado
Juan José José Galano FrutosJuan José José Galano Frutos
Juan José José Galano Frutos
MVMaria Valls
Maria Valls
AAAndrés Antón
Andrés Antón

8 December 2019 in Briefings in Bioinformatics
Verified
Journal Article
Open access
Juan José José Galano FrutosJuan José José Galano Frutos
Juan José José Galano Frutos
HGHelena García-Cebollada
Helena García-Cebollada
Javier SanchoJavier Sancho
Javier Sancho
The increasing ease with which massive genetic information can be obtained from patients or healthy individuals has stimulated the development of interpretive bioinformatics tools as aids in clinical practice. Most such tools analyze evolutionary information and simple physical–chemical properties to predict whether replacement of one amino acid residue with another will be tolerated or cause disease. Those approaches achieve up to 80–85% accuracy as binary classifiers (neutral/pathogenic). As such accuracy is insufficient for medical decision to be based on, and it does not appear to be increasing, more precise methods, such as full-atom molecular dynamics (MD) simulations in explicit solvent, are also discussed. Then, to describe the goal of interpreting human genetic variations at large scale through MD simulations, we restrictively refer to all possible protein variants carrying single-amino-acid substitutions arising from single-nucleotide variations as the human variome. We calculate its size and develop a simple model that allows calculating the simulation time needed to have a 0.99 probability of observing unfolding events of any unstable variant. The knowledge of that time enables performing a binary classification of the variants (stable-potentially neutral/unstable-pathogenic). Our model indicates that the human variome cannot be simulated with present computing capabilities. However, if they continue to increase as per Moore’s law, it could be simulated (at 65°C) spending only 3 years in the task if we started in 2031. The simulation of individual protein variomes is achievable in short times starting at present. International coordination seems appropriate to embark upon massive MD simulations of protein variants.

1 July 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CSCarmen Suay-Corredera
Carmen Suay-Corredera
MPMaria Rosaria Pricolo
Maria Rosaria Pricolo
EHElías Herrero-Galán
Elías Herrero-Galán
DVDiana Velázquez-Carreras
Diana Velázquez-Carreras
DSDavid Sánchez-Ortiz
David Sánchez-Ortiz
JAJorge Alegre-Cebollada
Jorge Alegre-Cebollada
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM.

7 June 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSSandra Salillas
Sandra Salillas
MAMiriam Alías
Miriam Alías
VMValérie Michel
Valérie Michel
AMAlejandro Mahía
Alejandro Mahía
ALAinhoa Lucía
Ainhoa Lucía
Javier SanchoJavier Sancho
Javier Sancho

26 July 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Juan José José Galano FrutosJuan José José Galano Frutos
Juan José José Galano Frutos
MAMiriam Alías
Miriam Alías
RPReyes Pérez
Reyes Pérez
AVAdrian Velazquez-Campoy
Adrian Velazquez-Campoy
PHPaul S. Hoffman
Paul S. Hoffman
Javier SanchoJavier Sancho
Javier Sancho